Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Warby Parker Inc.NYSE: WRBY

Operating Income · Q2 FY2026 · quarter ended Jun 2026

Operating income turns positive

Q2 FY2026 operating income was $3.17M, compared with -$4.53M a year earlier. Trailing-twelve-month operating income was $1.55M.

Context

  • Operating income amounted to 0.6% of revenue in FY2025, down 3.3 pp from a year earlier.
  • Operating income grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 10 analysts of $59.61M (+1217.2%) for the fiscal year ending Dec 2026, a step up from the +82.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.17M+90.0% QoQ
Last fiscal yearDec 2025
-$5.34M+82.3% YoY
LTMJun 2026
$1.55M+108.6% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+170.0%+265.3%+95.3 pp
1 year+82.3%+1217.2%+1134.9 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
(5.34M) USD
Year-over-year change
+82.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 operating income of $1.55M is the 8th highest of the 10 companies compared; the peer median is $174.4M.
  • Its year-over-year change of +108.6% is the 2nd highest of 10, against a peer median of +22.3%.
  • Operating income amounts to 0.2% of revenue for WRBY, versus a peer median of 18.2%.
WRBY Competitors Peer median
Operating Income for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$2.76B +69.9%+68.8%25.4%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$395.54M +22.3%+9.0%16.9%
HAEHaemonetics CorporationLTM Jun 2026$245.74M +13.7%+15.7%18.2%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$216M +125.2%—5.9%
ITGRInteger Holdings CorporationLTM Jul 2026$174.4M -20.5%+22.9%9.5%
ICUIICU Medical, Inc.LTM Jun 2026$108.76M +56.7%—5.0%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$73.06M +37.8%+36.3%28.5%
WRBYWarby Parker Inc.LTM Jun 2026$1.55M +108.6%—0.2%
BEAMBeam Therapeutics Inc.LTM Jun 2026-$378.02M +15.2%—242.3%
QDELQuidelOrtho CorporationLTM Mar 2026-$979.2M -475.0%—36.9%
Peer median (excluding WRBY) $174.4M+22.3%+22.9%18.2%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.